ZFIN ID: ZDB-FISH-200729-6
Fish name: pgrmc2ecu10/ecu10
Genotype: pgrmc2ecu10/ecu10
Targeting Reagent: none
HUMAN DISEASE MODELED by pgrmc2ecu10/ecu10
No data available
GENE EXPRESSION
Gene expression in pgrmc2ecu10/ecu10
RNA expression
Expressed Gene Structure Conditions Figures
adam8b standard conditions Fig. 4 from Wu et al., 2019
adamts1 standard conditions Fig. 4 from Wu et al., 2019
adamts8a standard conditions Fig. 4 from Wu et al., 2019
adamts9 standard conditions Fig. 4 from Wu et al., 2019
ar standard conditions Fig. 5 from Wu et al., 2019
cyp11a1 standard conditions Fig. 5 from Wu et al., 2019
cyp17a1 standard conditions Fig. 5 from Wu et al., 2019
cyp19a1a standard conditions Fig. 5 from Wu et al., 2019
egfra standard conditions Fig. 5 from Wu et al., 2019
esr1 standard conditions Fig. 5 from Wu et al., 2019
esr2a standard conditions Fig. 5 from Wu et al., 2019
esr2b standard conditions Fig. 5 from Wu et al., 2019
fshb standard conditions Fig. 5 from Wu et al., 2019
fshr standard conditions Fig. 5 from Wu et al., 2019
gnrh3 standard conditions Fig. 5 from Wu et al., 2019
gnrhr2 standard conditions Fig. 5 from Wu et al., 2019
gnrhr4 standard conditions Fig. 5 from Wu et al., 2019
hmgcra standard conditions Fig. 5 from Wu et al., 2019
hmgcrb standard conditions Fig. 5 from Wu et al., 2019
hsd3b1 standard conditions Fig. 5 from Wu et al., 2019
hsd17b1 standard conditions Fig. 5 from Wu et al., 2019
igf1 standard conditions Fig. 5 from Wu et al., 2019
insig1 standard conditions Fig. 5 from Wu et al., 2019
lhb standard conditions Fig. 5 from Wu et al., 2019
lhcgr standard conditions Fig. 5 from Wu et al., 2019
mmp2 standard conditions Fig. 4 from Wu et al., 2019
mmp9 standard conditions Fig. 4 from Wu et al., 2019
paqr5a standard conditions Fig. 4 from Wu et al., 2019
paqr6 standard conditions Fig. 4 from Wu et al., 2019
paqr7a standard conditions Fig. 4 from Wu et al., 2019
paqr7b standard conditions Fig. 4 from Wu et al., 2019
paqr8 standard conditions Fig. 4 from Wu et al., 2019
pgr standard conditions Fig. 3 from Wu et al., 2019
star standard conditions Fig. 5 from Wu et al., 2019
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in pgrmc2ecu10/ecu10
Phenotype Conditions Figures
brain hsd3b1 expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
brain fshb expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
liver igf1 expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
oocyte maturation decreased process quality, abnormal standard conditions Fig. 4 from Wu et al., 2019
oocyte maturation decreased process quality, ameliorated chemical treatment: progestin Fig. 4 from Wu et al., 2019
oocyte stage III pgr expression decreased amount, abnormal standard conditions Fig. 3 from Wu et al., 2019
oocyte stage III adamts1 expression increased amount, abnormal standard conditions Fig. 4 from Wu et al., 2019
oocyte stage IV mmp9 expression decreased amount, abnormal standard conditions Fig. 4 from Wu et al., 2019
oocyte stage IV pgr expression decreased amount, abnormal standard conditions Fig. 3 from Wu et al., 2019
oocyte stage IV adamts9 expression decreased amount, abnormal standard conditions Fig. 4 from Wu et al., 2019
oocyte stage IV adam8b expression increased amount, abnormal standard conditions Fig. 4 from Wu et al., 2019
ovarian follicle stage I increased amount, abnormal standard conditions Fig. 3 from Wu et al., 2019
ovarian follicle stage II decreased amount, abnormal standard conditions Fig. 3 from Wu et al., 2019
ovarian follicle stage III decreased amount, abnormal standard conditions Fig. 3 from Wu et al., 2019
ovarian follicle stage IV decreased amount, abnormal standard conditions Fig. 3 from Wu et al., 2019
ovary cyp17a1 expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary lhcgr expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary esr1 expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary ar expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary egfra expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary fshr expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary hsd3b1 expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary esr2b expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary cyp11a1 expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary hsd17b1 expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary esr2a expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary star expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary cyp19a1a expression decreased amount, abnormal standard conditions Fig. 5 from Wu et al., 2019
ovary decreased size, abnormal standard conditions Fig. 3 from Wu et al., 2019
oviposition decreased frequency, abnormal standard conditions Fig. 3 from Wu et al., 2019
reproduction decreased efficacy, abnormal standard conditions Fig. 3 from Wu et al., 2019
yolk normal size, normal standard conditions Fig. 4 from Wu et al., 2019

CITATIONS  (2)